ࡱ> lo  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijknR F \S,mWorkbookSummaryInformation(DocumentSummaryInformation8  Z@\pBadri A. Ba= ThisWorkbook=PCalibri1?Calibri14Calibri14Calibri1 Calibri1 Calibri1Calibri1Calibri1 Calibri1Times New Roman1Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)""#,##0;""\-#,##0""#,##0;[Red]""\-#,##0""#,##0.00;""\-#,##0.00#""#,##0.00;[Red]""\-#,##0.0072_ ""* #,##0_ ;_ ""* \-#,##0_ ;_ ""* "-"_ ;_ @_ .)_ * #,##0_ ;_ * \-#,##0_ ;_ * "-"_ ;_ @_ ?:_ ""* #,##0.00_ ;_ ""* \-#,##0.00_ ;_ ""* "-"??_ ;_ @_ 61_ * #,##0.00_ ;_ * \-#,##0.00_ ;_ * "-"??_ ;_ @_ \$#,##0_);\(\$#,##0\)\$#,##0_);[Red]\(\$#,##0\) \$#,##0.00_);\(\$#,##0.00\)% \$#,##0.00_);[Red]\(\$#,##0.00\)"Yes";"Yes";"No""True";"True";"False""On";"On";"Off"],[$ -2]\ #,##0.00_);[Red]\([$ -2]\ #,##0.00\)                                            ff        P  P        `          a>       20% - Accent1 20% - Accent2 20% - Accent3 20% - Accent4 20% - Accent5 20% - Accent6 40% - Accent1 40% - Accent2 40% - Accent3 40% - Accent4 40% - Accent5 40% - Accent6 60% - Accent1 60% - Accent2 60% - Accent3 60% - Accent4 60% - Accent5! 60% - Accent6 "Accent1 #Accent2 $Accent3 %Accent4 &Accent5 'Accent6(Bad) Calculation* Check Cell+,-./Explanatory Text 0Good1 Heading 12 Heading 23 Heading 34 Heading 4 5Input6 Linked Cell 7Neutral 8Note 9Output: ;Title <Total= Warning Text8dq:F3ffff̙̙3f3fff3f3f33333f33333\`"aSupplementary Table 44 4rno04360 Axon guidanceSlit3rno04020Calcium signaling pathway172/6821Cckarrno04024cAMP signaling pathway187/6821rno04810 Regulation of actin cytoskeleton192/6821rno04015Rap1 signaling pathway195/6821Supplementary Table 4. The list of KEGG enrichment analysis of downregulated genes between HKL treated UC samples and water treated UC samples.rno05323Rheumatoid arthritisrno05414Dilated cardiomyopathyrno04146 Peroxisome78/6821rno05132Salmonella infectionLbprno05010Alzheimer's disease162/6821Cox6a2,LOC103694380rno05016Huntington's disease163/6821 Sod2,Cox6a2rno04350TGF-beta signaling pathwayrno04666 Fc gamma R-mediated phagocytosis81/6821 LOC498276rno05215Prostate cancerrno04650)Natural killer cell mediated cytotoxicityrno04211Longevity regulating pathwayrno01522Endocrine resistance88/6821rno04915Estrogen signaling pathway91/6821rno049334AGE-RAGE signaling pathway in diabetic complications95/6821rno05200Pathways in cancer353/6821Ccne1,Mmp9,Birc5,Fgf23rno05205Proteoglycans in cancer189/6821Mmp9,LOC103694380rno04931Insulin resistancerno04670$Leukocyte transendothelial migrationrno04151PI3K-Akt signaling pathway292/6821Ccne1,Cd19,Fgf23rno04071Sphingolipid signaling pathwayrno04722Neurotrophin signaling pathwayNtrk2rno05162Measlesrno04120Ubiquitin mediated proteolysis121/6821Ube2crno00190Oxidative phosphorylation122/6821Cox6a2rno05034 Alcoholism123/6821rno04630Jak-STAT signaling pathway130/6821Gfaprno05012Parkinson's disease131/6821rno05224 Breast cancerrno04261&Adrenergic signaling in cardiomyocytes136/6821rno04390Hippo signaling pathway138/6821rno04150mTOR signaling pathwayrno04530Tight junction153/6821Gata4rno04141+Protein processing in endoplasmic reticulum156/6821Cryaa!Thyroid hormone signaling pathway107/6821 Gata4,Atp1a3rno04611Platelet activation Fgg,LOC498276rno05166HTLV-I infection247/6821$Il1r2,RT1-CE3,RT1-T24-1,LOC103694380rno04930Type II diabetes mellitusrno04144 Endocytosis248/6821Tfrc,Ldlr,RT1-CE3,RT1-T24-1rno04623Cytosolic DNA-sensing pathwayRipk3rno049619Endocrine and other factor-regulated calcium reabsorptionrno00280*Valine, leucine and isoleucine degradationrno04152AMPK signaling pathway115/6821 Ccna2,Scd2rno05160 Hepatitis Crno01212Fatty acid metabolism48/6821rno05144Malariarno05014#Amyotrophic lateral sclerosis (ALS)50/6821rno04068FoxO signaling pathway120/6821 Sod2,Ccnb1rno04210 Apoptosis125/6821Birc5,LOC103694380rno05321 Inflammatory bowel disease (IBD)rno05210Colorectal cancer56/6821rno04060&Cytokine-cytokine receptor interaction206/6821Il1r2,Tnfsf8,LOC103694380rno04310Wnt signaling pathway133/6821 Sfrp1,Sfrp4rno04621#NOD-like receptor signaling pathway135/6821Ripk3,LOC103694380rno04213/Longevity regulating pathway - multiple speciesSod2rno04664Fc epsilon RI signaling pathwayrno05202'Transcriptional misregulation in cancer143/6821 Il1r2,Mmp9rno05218MelanomaFgf23rno04920Adipocytokine signaling pathway68/6821rno04971Gastric acid secretionrno05222Small cell lung cancerCcne1rno04022cGMP-PKG signaling pathway154/6821rno03320PPAR signaling pathwayrno05410!Hypertrophic cardiomyopathy (HCM)rno04925#Aldosterone synthesis and secretionLdlrButanoate metabolism24/6821rno01040'Biosynthesis of unsaturated fatty acidsScd2rno04977 Vitamin digestion and absorptionPnliprno05310Asthma LOC103694380rno05206MicroRNAs in cancerCcne1,Mmp9,Cyp1b1rno04064NF-kappa B signaling pathway77/6821Lbp,LOC103694380rno00500Starch and sucrose metabolism26/6821 LOC103689940rno04950$Maturity onset diabetes of the youngBhlha15rno04911Insulin secretion Atp1a3,Cckarrno04914'Progesterone-mediated oocyte maturation Ccna2,Ccnb1rno05146 Amoebiasis82/6821Il1r2,LOC103694380rno01523Antifolate resistance28/6821rno04932)Non-alcoholic fatty liver disease (NAFLD)142/6821Cyp2e1,Cox6a2,LOC103694380rno04620$Toll-like receptor signaling pathwayrno04014Ras signaling pathway208/6821Pla2g1b,Pla2g2d,Pla2g2a,Fgf23rno04215Apoptosis - multiple species31/6821Birc5rno03410Base excision repairrno05020Prion diseasesC6rno03030DNA replicationrno00240Pyrimidine metabolism92/6821rno05143African trypanosomiasisrno04066HIF-1 signaling pathway96/6821 Tfrc,Timp1rno04960)Aldosterone-regulated sodium reabsorption37/6821rno05219Bladder cancerMmp9rno04660!T cell receptor signaling pathwayCd8a,LOC103694380rno05142)Chagas disease (American trypanosomiasis)rno05145 Toxoplasmosis102/6821Ldlr,LOC103694380rno04114Oocyte meiosis105/6821 Ccne1,Ccnb1rno04010MAPK signaling pathway239/6821Il1r2,Ntrk2,Fgf23,LOC103694380rno00380Tryptophan metabolismCyp1b1rno04919 Ldlr,Cyp1b1rno00982!Drug metabolism - cytochrome P450 Cyp2e1,Fmo1rno05169Epstein-Barr virus infection194/6821 Ccna2,Cd19,RT1-CE3,RT1-T24-1,Cr2rno01100Metabolic pathways 1166/6821Pla2g1b,Upp1,Cyp51,Sqle,Cel,Mthfd2,Cyp2e1,Alpl,Hmgcs1,Idi1,Pla2g2d,Pla2g2a,Pnlip,Pnliprp1,Pnliprp2,Cox6a2,Dhcr7,Cyp11b2,Tk1,Lss,LOC103689940rno03450Non-homologous end-joiningGenetic Information Processing12/6821Fen1rno05134 Legionellosis51/6821C3,LOC103694380rno04668TNF signaling pathway99/6821Mmp9,Ripk3,LOC103694380rno05320Autoimmune thyroid disease52/6821RT1-CE3,RT1-T24-1rno00730Thiamine metabolism13/6821Alplrno05152 Tuberculosis151/6821Lbp,LOC498276,C3,LOC103694380rno00790Folate biosynthesis14/6821rno04622%RIG-I-like receptor signaling pathway57/6821Isg15,LOC103694380rno04270"Vascular smooth muscle contraction111/6821rno04110 Cell cycle112/6821Ccne1,Ccna2,Ccnb1rno00670One carbon pool by folate17/6821Mthfd2rno04380Osteoclast differentiation113/6821LOC498276,LOC103694380,Oscarrno05168Herpes simplex infection169/6821!RT1-CE3,RT1-T24-1,C3,LOC103694380rno05416Viral myocarditis65/6821rno04976Bile secretion Ldlr,Atp1a3rno05133 Pertussisrno05204Chemical carcinogenesis67/6821rno04918Thyroid hormone synthesis Duoxa2,Atp1a3rno04964'Proximal tubule bicarbonate reclamationAtp1a3rno04970Salivary secretion70/6821 Atp1a3,Aqp5rno01524Platinum drug resistance Birc5,Top2arno04260Cardiac muscle contraction Cox6a2,Atp1a3rno00650rno00565Ether lipid metabolism40/6821rno04612#Antigen processing and presentation72/6821#Cd8a,RT1-CE3,RT1-T24-1,LOC103694380rno05322Systemic lupus erythematosusC6,LOC498276,C3,LOC103694380rno05332Graft-versus-host disease45/6821RT1-CE3,RT1-T24-1,LOC103694380rno05330Allograft rejection47/6821rno05161 Hepatitis B126/6821#Ccne1,Ccna2,Mmp9,Birc5,LOC103694380rno00900Terpenoid backbone biosynthesis2/9821/6821 Hmgcs1,Idi1rno04940Type I diabetes mellitusrno00140Steroid hormone biosynthesis60/6821Cyp2e1,Cyp11b2,Cyp1b1rno04115p53 signaling pathwayCellular Processes61/6821Ccne1,Gtse1,Ccnb1rno05140 Leishmaniasis62/6821LOC498276,C3,LOC103694380rno04145 Phagosome148/6821#Tfrc,RT1-CE3,RT1-T24-1,LOC498276,C3rno05340Primary immunodeficiency33/6821 Cd8a,Cd19rno00983Drug metabolism - other enzymes34/6821Upp1,Tk1rno04973%Carbohydrate digestion and absorption36/6821Atp1a3,LOC103689940rno04080'Neuroactive ligand-receptor interaction275/6821,LOC286960,Prss3b,Plg,Prss3,Prss1,Prss2,Cckarrno04216 Ferroptosis Tfrc,Slc7a11rno00564Glycerophospholipid metabol<pism83/6821rno05203Viral carcinogenesis181/6821 Ccne1,Ccna2,RT1-CE3,RT1-T24-1,C3rno05418&Fluid shear stress and atherosclerosis132/6821Il1r2,Mmp9,Nppc,LOC103694380rno04978Mineral absorption42/6821 Steap1,Atp1a3rno00072*Synthesis and degradation of ketone bodies1/989/6821Hmgcs1rno00980,Metabolism of xenobiotics by cytochrome P45046/6821 Cyp2e1,Cyp1b1rno04913Ovarian steroidogenesisID DescriptionClass GeneRatioBgRatio Enrich_factorPvalueFDR GeneCountGeneIDrno04972Pancreatic secretionOrganismal Systems21/9893/6821Pla2g1b,Cel,Cpa1,LOC286960,Prss3b,Cela2a,Pla2g2d,Pla2g2a,Pnlip,Pnliprp1,Pnliprp2,Ctrb1,Ctrl,Atp1a3,Cela3b,Cpa2,Cpb1,Prss3,Prss1,Prss2,Cckarrno04974 Protein digestion and absorption14/9875/6821YCpa1,LOC286960,Prss3b,Cela2a,Ctrb1,Ctrl,Atp1a3,Cela3b,Col11a1,Cpa2,Cpb1,Prss3,Prss1,Prss2rno04610#Complement and coagulation cascades11/9874/68216Serpinb2,Plg,C6,Fgg,Kng1,Serpina1,Cr2,Vsig4,C3,Cfb,Cfirno04975Fat digestion and absorption8/9838/68218Clps,Pla2g1b,Cel,Pla2g2d,Pla2g2a,Pnlip,Pnliprp1,Pnliprp2rno00100Steroid biosynthesis Metabolism5/9819/6821Cyp51,Sqle,Cel,Dhcr7,Lssrno04640Hematopoietic cell lineage80/68210Tfrc,Cd8a,Il1r2,Cd19,Ms4a1,Cd22,Cr2,LOC103694380rno05150Staphylococcus aureus infectionHuman Diseases6/9843/6821Plg,Fgg,LOC498276,C3,Cfb,Cfirno00591Linoleic acid metabolism4/9832/6821Pla2g1b,Cyp2e1,Pla2g2d,Pla2g2arno00592alpha-Linolenic acid metabolism3/98Pla2g1b,Pla2g2d,Pla2g2arno05164 Influenza A7/98146/68213LOC286960,Prss3b,Plg,Prss3,Prss1,Prss2,LOC103694380rno04657IL-17 signaling pathway84/6821$S100a9,S100a8,Lcn2,Mmp9,LOC103694380rno00561Glycerolipid metabolism54/6821Cel,Pnlip,Pnliprp1,Pnliprp2rno04662!B cell receptor signaling pathway66/6821Cd79b,Cd19,Cd22,Cr2rno04514Cell adhesion molecules (CAMs)$Environmental Information Processing141/6821+Cd8a,Siglec1,Cd22,RT1-CE3,RT1-T24-1,Glycam1rno00590Arachidonic acid metabolism69/68212t thbogg3ʧ#S;Mq(JgSM #  {  = ` e P E y!!!"%#e#<!-L$_$X:%%`!-d&&t-X'_()e)-)*( ++&+,,3-0--LN../#]00%!1D1DT22b34D44`-(6C6Iu78C8!-O9C9f!-:D "!-X"!-T82X|CPp@,|C_EHEpE-EDXeC-xDpEDCCC DȄEEE"!D*C-`-hh(&hC-Hc}ԃ- Dԃ-Yd}ԃ-]`\8^,-ԃ-\ism83/6821rno05203Viral carcinogenesis181/6821 Ccne1,Ccna2,RT1-CE3,RT1-T24-1,C3rno05418&Fluid shear stress and atherosclerosis132/6821Il1r2,Mmp9,Nppc,LOC103694380rno04978Mineral absorption42/6821 Steap1,Atp1a3rno00072*Synthesis and degradation of ketone bodies1/989/6821Hmgcs1rno00980,Metabolism of xenobiotics by cytochrome P45046/6821 Cyp2e1,Cyp1b1rno04913Ovarian stecc||A+M}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-} 00_)}-}  00_)}-}  00_)}-}  00_)}-}  00_)}-}  00_)}-} 00_)}-} 00_)}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef[$ -}A} 00_)ef [$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L[$ -}A} 00_)L [$ -}A} 00_)23[$ -}A} 00_)23[$ -}A} 00_)23[$ -}A} 00_)23[$ -}A}  00_)23[$ -}A}! 00_)23 [$ -}-}: 00_)}-}; 00_)}A}1 00_)[$ -}A}2 00_)?[$ -}A}3 00_)23[$ -}-}4 00_)}A}( 00_)[$ -}A}0 a00_)[$ -}U}< 00_)[$ -##0.}-}- 00_)}-}. 00_)}}) }00_)[$ -##0.  }}* 00_)[$ -???##0.??? ??? ???}-}/ 00_)}-}= 00_)}A}6 }00_)[$ -}-}+ 00_)}-}, 00_)}A}" 00_)[$ -}A}# 00_)[$ -}A}$ 00_)[$ -}A}% 00_)[$ -}A}& 00_)[$ -}A}' 00_) [$ -}A}7 e00_)[$ -}}9 ???00_)[$ -???##0.??? ??? ???}}5 ??v00_)̙[$ -##0.  }}8 00_)[$ -##0.  }(}> 00_)}(}? 00_)}-}@ 00_)M 20% - Accent1 ef %M" 20% - Accent2 ef %M& 20% - Accent3 ef %M* 20% - Accent4 ef %M. 20% - Accent5 ef %M2 20% - Accent6  ef %M 40% - Accent1 L %M# 40% - Accent2 L渷 %M' 40% - Accent3 L %M+ 40% - Accent4 L %M/ 40% - Accent5 L %M3 40% - Accent6  Lմ %M 60% - Accent1 23 %M$ 60% - Accent2 23ږ %M( 60% - Accent3 23כ %M, 60% - Accent4 23 %M0 60% - Accent5 23 %M4 60% - Accent6  23 %AAccent1 O %A!Accent2 PM %A%Accent3 Y %A)Accent4 d %A-Accent5 K %A1Accent6  F %9Bad  % Calculation  }%  Check Cell  %????????? ??? Comma( Comma [0]&Currency. Currency [0]G5Explanatory Text %;Good  a%G Heading 1 I}%OG Heading 2 I}%?G Heading 3 I}%239 Heading 4 I}%uInput ̙ ??v% K Linked Cell }%ANeutral  e%3Normal %b Note  wOutput  ???%????????? ???$Percent1Title I}%MTotal %OO? Warning Text %XTableStyleMedium2PivotStyleLight16B Z@ ("bwv>  dMbP?_*+%&ffffff?'ffffff?(?)?" dXX333333?333333?U }  >  @    ч @  $ @ ʇ                    -    @ > > > > > > > > >  > > > > > >>n/@>>>5@  > > > > > >>L/[)@?y=?=~ >,@  > > > > > >>PG$@?59>?[UU_>~ >&@  > > > > > >>Vr ^N-@? i>?_>~ > @  > > > > > >>(ևP2@?˰|>>g'?~ >@  > > >  > > > >Ld ?@? y>>?|>?~ > @  >  >  >  > > >>ZXl#@?wR_>>k8F?~ >@  > > > > > > >>4ևf!@ >맻_VQ? >n?~ >@ > > > > > > >$4և%@ >9aQc? >*ݥ?~ >@ > > > > > > >K,Y @ >s? >cPJ?~ >@ > >  >! > > >" > h@ >?|? >p @ ># >$ >% > > >& >@q@ >{f}? >p @ >' >( >) > > >*> 5az@>\&UF?>Μ?~ >@  >+ >, >- >. > >/>)}j@>~^-?>Μ?~ >@  >0 >1 >2 > > >3>#@>59g?>Μ?~ >@  > > > > > >>%~ѓ?>Μ?~ >@  > > > > > >>3\`*@>Y : ?>Μ?~ >@  > > > > > >>3\`*@>Y : ?>Μ?~ >@  > > > > > >>j@>3 ?> r&?~ >@  > > > > > >>%5N@>{E?>*;E?~ >@  > > > > > >>@>(N筡?>qhgf ?~ >@  > > > > > >>w.ۃ@>vMRf?>qhgf ?~ >@  > > > > > >&>3\`*@>o?>)K?~ >@  > > > > > >>Wd ? @>vݥ?>*܇?~ >@  > > > > > >><=hb @>HF#?>*܇?~ >@  > > > > > >>|tV @>[YGeQP?>*܇?~ >@  > > > > > >>Jq@>dnd?>*܇?~ >@  > > > > > >> 5az@>V?>jE'?~ >@  > > > > > >>j`@>=е?>K?~ >@  > > > > > >>3\`*@>Ŵe`?>WV?~ >@  >Dl @! " # $ ч% @& ' $( @) ʇ* + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = - > ?  > > >. > > >X? >>Ԍ? >,?~ >@ > !> !> !> !> !>!>Vr ^N @!>6\?!>,?~ !>@ ! > "> "> "> "> ">">i: @">Խ?">2#՛9?~ ">@ " > #> #> #> #> #>#>sci?#>Y]^V?#>2#՛9?~ #>@ # > $> $> $> $> $>$>4az@$>:|?$>2#՛9?~ $>@ $ > %> %> %> %> %>%>w.ۃ @%>Sņ$?%>2#՛9?~ %>@ % > &> &> &> &> &>&>>\`*@&>bB G?&>2#՛9?~ &>? & > '> '> '> '> '>'>S5@'>W?'>sm(?~ '>@ ' > (> (> (> (> (>(>S5@(>W?(>sm(?~ (>@ ( >. )>/ )>0 )> )> )>)>)}j@)>5?)>sm(?~ )>@ ) >1 *>2 *>3 *> *> *>4*>'=ꭳ?*>*T?*>sm(?~ *>@ * >5 +>6 +>7 +> +> +>8+>}ʤ?+>;/_1?+> զ?~ +>5@ + >9 ,>: ,>; ,>< ,> ,>=,>E_3@,>bk?,> զ?~ ,>? , >> ->? ->@ -> -> ->A->?ی@->)E?-> զ?~ ->@ - >B .>C .>D .>. .> .>E.>4az@.>Z??.> զ?~ .>@ . >F />G />H /> /> />I/>j@/>\o?/> զ?~ />@ / >J 0>K 0>L 0> 0> 0>M0>j@0>t ?0> զ?~ 0>? 0 >N 1>O 1>P 1> 1> 1>Q1>$?I ?1>7OX?1> զ?~ 1>@ 1 >R 2>S 2>T 2> 2> 2>U2>لb@2>Vd~?2>t/?~ 2>? 2 >N 3>V 3>W 3> 3> 3>X3>J@3>/s??3>BG2?~ 3>@ 3 >Y 4>Z 4>[ 4> 4> 4>\4>˪O"?4>"pX?4>)meO?~ 4>@ 4 > 5>] 5>^ 5> 5> 5>_5>FǓV?5>nl)meO?~ 5>@ 5 >` 6>a 6>b 6> 6> 6>c6>j`@6>!ӆ?6>)meO?~ 6>? 6 >d 7>e 7>f 7> 7> 7>g7>Ŏ?7>N?7>)meO?~ 7>@ 7 >h 8>i 8>j 8> 8> 8>k8>[?8>#~^e?8>)meO?~ 8>@ 8 >l 9>m 9>n 9> 9> 9>o9>D!@9>An?9>EV1?~ 9>@ 9 >J :>p :>q :> :> :>*:>4az@:>U5VZ?:>EV1?~ :>@ : >r ;>s ;>t ;> ;> ;>*;>4az@;>U5VZ?;>EV1?~ ;>@ ; >B <>u <>v <> <> <>w<>b@<>V?<>ѵy ?~ <>@ < > =>x =>y => => =>3=>̋#@=>Qx?=> Ki I?~ =>@ = >z >>{ >>| >> >> >>>>w.ۃ @>>sٸ(?>> Ki I?~ >>? > >} ?>~ ?> ?> ?> ?>?>)njm??>M ??> Ki I?~ ?>@ ? >Dl@ @A B C D чE @F G $H @I ʇJ K L M N O P Q R S T U V W X Y Z [ \ ] - ^ _  @> @> @> @> @>@>I\`*?@> ÿa?@> Ki I?~ @>@ @ > A> A> A> A> A>A>˪O"?A> (j?A> Ki I?~ A>@ A > B> B> B> B> B>B>E_3@B>h0HE;?B> Ki I?~ B>? B > C> C> C> C> C>C>E_3@C>h0HE;?C> Ki I?~ C>? C > D> D> D> D> D>D>E_3@D>h0HE;?D> Ki I?~ D>? D > E> E> E> E> E>E>E_3@E>h0HE;?E> Ki I?~ E>? E > F> F> F> F> F>F>ϑ7QO?F>Erx ?F> Ki I?~ F>@ F > G> G> G>. G> G>G>?G>BA*vp?G>rY>ogp?~ G>@ G > H> H> H> H> H>H>j@H>Fz?H>rY>ogp?~ H>? H > I> I> I> I> I>I>j@I>Fz?I>rY>ogp?~ I>? I > J> J> J> J> J> J>Ad ??J>u?J>rY>ogp?~ J>@ J > K> K> K> K> K> K>Ad ??K>u?K>rY>ogp?~ K>@ K > L> L> L> L> L>L>ϓ8i)?L>l=#?L>rY>ogp?~ L>@ L > M> M> M> M> M>M>لb@M>).]V[?M>rY>ogp?~ M>? M > N> N> N> N> N>N>[?N>qźe?N>rY>ogp?~ N>@ N > O> O> O> O> O>O>W27?O>"Y;y?O>rY>ogp?~ O>@ O > P> P> P>. P> P>P>&j?P>/>g?P>7?~ P>@ P > Q> Q> Q> Q> Q>Q>ZN9@Q>M-?Q>lzV?~ Q>? Q > R> R> R>< R> R>R>>4ևf@R>x|M?R>s[o՞?~ R>? R >> S> S> S> S> S>S>>4ևf@S>x|M?S>s[o՞?~ S>? S > T> T>  T>< T> T>T>4az@T>/X?T> g?~ T>? T >> U>  U>  U> U> U> U>S5?U>}k!y?U> g?~ U>@ U > V>  V> V> V> V>V>u`@V>J+?V>z?~ V>? V > W> W> W>. W> W>W>E_3?W>~^6?W>I8?~ W>@ W > X> X> X> X> X>X>˪O"?X>gfe?X>I8?~ X>? X >} Y> Y> Y> Y> Y>Y>˪O"?Y>gfe?Y>I8?~ Y>? Y > Z> Z> Z> Z> Z>EZ>F,d?Z>mh%?Z>I8?~ Z>@ Z > [> [> [> [> [>E[>F,d?[>mh%?[>I8?~ [>@ [ >B \> \> \> \> \> \>(ی?\>Xֳ?\>[N(?~ \>@ \ >! ]>" ]># ]> ]> ]>$]>WƞH6?]>O9ɤ?]>[N(?~ ]>@ ] >% ^>& ^>' ^>. ^> ^>(^>DLa?^>nť?^>[N(?~ ^>@ ^ >) _>* _>+ _> _> _>_>w.ۃ?_>Ӫ6?_>[N(?~ _>? _ >,Dl` @a b c d чe @f g $h @i ʇj k l m n o p q r s t u v w x y z { | } - ~   `>- `>s `> `> `>t`>?`>p각C?`>[N(?~ `>@ ` >u a>v a>w a> a> a>\a>?a>H'|?a>[N(?~ a>@ a >x b>y b>z b> b> b>{b> Eh?b>GE?b>[N(?~ b>@ b >| c>} c>~ c> c> c>c>eU?c>?ka6b?c>[N(?~ c>? c > d> d> d> d> d>d>DN9?d>e?d>[N(?~ d>@ d > e> e> e> e> e>e>S5?e>m.?e>[N(?~ e>? e > f> f> f> f> f>f>S5?f>m.?f>[N(?~ f>? f >} g> g> g> g> g>g>@}j?g>@2?g>[N(?~ g>? g > h> h> h>. h> h>h>(C^?h>,?h>[N(?~ h>@ h > i> i> i> i> i>i>(C^?i>,?i>[N(?~ i>@ i >! j> j> j> j> j>j>E_3?j>b1?j>[N(?~ j>? j > k> k> k> k> k>k>E_3?k>b1?k>[N(?~ k>? k > l> l> l> l> l>l> ME?l>U7?l>뎦?~ l>? l > m> m> m>. m> m>m>j?m> z?m>뎦?~ m>@ m > n> n> n> n> n>n>} yp?n>"֍ZF?n>9?~ n>@ n > o> o> o> o> o>&o>@q?o>7e?o>9?~ o>? o > p> p> p> p> p>p>لb?p>2@?p>9? *?~ p>? p > q> q> q>. q> q>q>U7?q> |R?q>d?~ q>@ q > r> r> r>. r> r>r>zҊ*?r>[?r>d?~ r>@ r > s> s> s> s> s>s>CB?s>Wܞ?s>d?~ s>@ s > t> t> t> t> t>t>j?t>Y'?t>d?~ t>? t > u> u> u> u> u>u>DN9?u>ݹ?u>J6/?~ u>? u > v> v> v> v> v>v>X&?v>A,\?v>3-?~ v>@ v > w> w> w> w> w>*w>5az?w>lM^?w>3-?~ w>? w > x> x> x> x> x>x>u`?x>?x>3-?~ x>? x > y> y> y> y> y>y>u`?y>?y>3-?~ y>? y >} z> z> z> z> z>3z>#?z>3WBW E?z>3-?~ z>? z > {> {> {>. {> {>{>?{>}?{>3-?~ {>@ { >u |> |> |> |> |>|>O"?|>[?|>3-?~ |>? | > }> }> }> }> }>}>O"?}>[?}>3-?~ }>? } > ~> ~> ~> ~> ~>~>?~>c^?~>3-?~ ~>? ~ > > > > > >>?>c^?>3-?~ >?  >Dl @    ч @  $ @ ʇ                    -    > > > > >>?>c^?>3-?~ >? > > > > > >>smi?>E蒷?>3-?~ >? > > > > > >>smi?>E蒷?>3-?~ >? > > > > > >>pVB?>ّ?>3-?~ >@ > > > > > >!>dT?>R8&|?>3-?~ >@ >" ># >$ >. > > >Sd ??>ke?>3-?~ >? > >% >& > > >'>pVB?>jAǴ(?>3-?~ >? >( >) >* > > >>ϓ8i)?>:3-?~ >? > >+ >, > > >>i27?>[pq?>3-?~ >? > >- >. > > >">w.ۃ?>DH"?>3-?~ >? > >/ >0 > > >1>ϑ7QO?>VN?>UIV}?~ >? > >2 >3 > > >4>ey?>*?>$ ?~ >? > >5 >6 > > >7>E(q?>?/?>l]?~ >? > >8 >9 > > >:>UB}k$?>l]?~ >@ >; >< >= > > >>>`a?>تCW?>Zn#?~ >@ >? >@ >A > > > >:ی?>p*e?>u&On?~ >? > >B >C > > >$>WƞH6?>Teu?>zl?~ >? > >D >E >. > >F>EJ?>+*?>96*?~ >@ >G >H >I >. > >>C^?>ʏ?>96*?~ >? > >J >K > > >>C^?>ʏ?>96*?~ >? >L >M >N > > >>C^?>ʏ?>96*?~ >? > >O >P >< > >Q>9$;h?>8?>? >R >S >T > > >U>(~A?>f?>? >V >W >X > > >Y>5 {?>φMrİ?>? >L >Z >[ >. > >\>@!?>i0T6?>;L8-?~ >? >] >^ >_ > > >`>'ٹ?>xH?>;L8-?~ >? >V >a >b > > >>zҊ*?>' @)k?>;L8-?~ >? > >c >d > > >e>l`?>+[?>;L8-?~ >? >} >f >g >. > >h>ȋ#?>go硾?>;L8-?~ >? > >i >j >. > >>N%^?>'?>IӾu>?~ >? > >k >l > > >m>yfU?>ZZ?>\a?~ >? >n >o >p >< > >q>jmi?>0%F?>\a?~ >? >rDl @    ч > > > > >>pVB?>MkRI?>Z)?~ >? > > > >. > >>r?>ݖm?>@U?~ >? > > > >. > > >kR.?>$-?>aW,?~ >? >} > > > > > >E_3?>&&" ?>aW,?~ >? > > > >. > >>U$!?>aW,?>aW,?~ >? >\P>@@ 7 Sheet1ggD&<3   Oh+'0@H\p ' Microsoft Jenny A.Microsoft Macintosh Excel@,5o@~ ՜.+,0 PXl t| ' Microsoft Supplementary Table 4  Worksheets FMicrosoft Excel Sheet8FIBExcel.Sheet.8CompObj T